AbbVie Makes $63B Bid for Botox Maker Allergan - NBC4 Washington

AbbVie Makes $63B Bid for Botox Maker Allergan

Regulators and Allergan shareholders still need to approve the deal

    processing...

    NEWSLETTERS

    Famous Showdowns Between Outlaws and the Law
    AP
    This March 20, 2002 file photo shows a vial of Botox, made by Allergan. (AP Photo/Damian Dovarganes)

    AbbVie is buying Botox maker Allergan in a cash-and-stock deal valued at about $63 billion.

    The maker of the blockbuster immune disorder treatment Humira said Tuesday that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. That amounts to $188.24 per share, or a 45% premium to Allergan's closing price Monday.

    Shares of Allergan Plc, based in Dublin, Ireland, jumped nearly 30% before the opening bell.

    AbbVie shareholders will own 83% of the specialty drug company combination after the deal's completion while Allergan shareholders will have a 17% stake.

    Woman Is Reunited With Missing Dog After 57-Day Search

    [NATL] Woman Is Reunited With Missing Dog After 57-Day Search

    A Washington State woman was finally reunited with her border collie, who went missing while on vacation in Montana.

    (Published 2 hours ago)

    Regulators and Allergan shareholders still have to approve the deal.

    Shares of AbbVie Inc., based in North Chicago, Illinois, sank 10%.